Doug Whitney, 76, carries a rare PSEN2 genetic mutation that causes early-onset Alzheimer's but shows no cognitive decline ...

The U.S. Food and Drug Administration has approved a second blood test to improve the detection of Alzheimer’s disease. The ...

Doug Whitney from Seattle appeared to be destined to develop Alzheimer’s disease — but against all genetic odds, he has ...

The FDA has cleared Roche's Elecsys pTau181 test, a blood-based biomarker test for Alzheimer's disease, allowing for earlier ...

The Food and Drug Administration has given approval for a blood test that will rule out if someone has Alzheimer’s disease ...

Researchers at USC have created the first method to noninvasively measure microscopic blood vessel pulses in the human brain.

The new tool is a blood test. The FDA just gave it the green light to help doctors rule out Alzheimer's Disease. Statistics ...

New research from the University of Miami’s Miller School of Medicine has found striking similarities between the brains of ...

Previous research investigating sex differences in brain ageing has shown mixed results, Ravndal adds. Several studies have ...

Scientists have found a potential new treatment target for Alzheimer’s. It comes after a novel technique improved cognitive ...

Roche Diagnostics said on Monday the U.S. Food and Drug Administration cleared its and partner Eli Lilly's blood test as an ...

The prevalence of Alzheimer's disease (AD) is approximately two times higher in African Americans (AA) compared to ...